Taken together, these observations suggest that the oncogenic activities of PLAG1 is at least partly mediated by IGF2 signaling and that IGF2 signaling is a potential therapeutic target in pleomorphic adenoma and hepatoblastoma and possibly also in lipoblastoma. This evidence concerns the gene PLAG1 and lipoblastoma.